Details
Stereochemistry | ACHIRAL |
Molecular Formula | F.Na |
Molecular Weight | 41.9882 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[F-].[Na+]
InChI
InChIKey=PUZPDOWCWNUUKD-UHFFFAOYSA-M
InChI=1S/FH.Na/h1H;/q;+1/p-1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | FH |
Molecular Weight | 20.0063 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.codifa.it/farmaci/e/elmex-gel-dentale-gel-olaflur-e-dectaflur-e-sodio-fluoruro-anticariehttps://www.ncbi.nlm.nih.gov/pubmed/24604256Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/olaflur.html | https://www.ncbi.nlm.nih.gov/pubmed/15528912 | https://clinicaltrials.gov/ct2/show/record/NCT00268138 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/4872.pdf
Sources: http://www.codifa.it/farmaci/e/elmex-gel-dentale-gel-olaflur-e-dectaflur-e-sodio-fluoruro-anticariehttps://www.ncbi.nlm.nih.gov/pubmed/24604256
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/olaflur.html | https://www.ncbi.nlm.nih.gov/pubmed/15528912 | https://clinicaltrials.gov/ct2/show/record/NCT00268138 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/4872.pdf
Oleylamine (or oleamine) is a versatile and flexible reagent in synthesis as well as the desired surface ligand for the synthesis of nanoparticles. This compound is rather toxic to mammalian organism.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
An improved method for emergent decontamination of ocular and dermal hydrofluoric acid splashes. | 2004 Aug |
|
Successful extracorporeal life support after potentially fatal pulmonary oedema caused by inhalation of nitric and hydrofluoric acid fumes. | 2007 Oct |
|
Oleylamine as a beneficial agent for the synthesis of CoFe₂O₄ nanoparticles with potential biomedical uses. | 2014 May 7 |
|
Cytotoxicity of organic surface coating agents used for nanoparticles synthesis and stability. | 2015 Jun |
|
Allergic contact cheilitis caused by olaflur in toothpaste. | 2017 Jan |
Patents
Sample Use Guides
Brushing your teeth thoroughly with the preparation once a week. Just use elmex dental gel using a regular toothbrush for a period of 2-3 minutes, rinse normally. The total time of application (brushing and residence time) should not exceed five minutes.
Route of Administration:
Dental
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3183150
The outer 50-100 mkm of the surface of freshly extracted human incisors was removed by grinding and polishing, thus removing not only the pellicle from the surface but also the outer mineral layer, which in general shows the greatest variation in chemical constituents. Amine fluoride 297 (AmF 297) were dissolved in distilled water. After adsorption of aminefluorides on the enamel for 2 min at a volume to area ratio of 25 cm3/cm2, the enamel surfaces were rinsed with distilled water and allowed to dry for several hours at room temperature in an enclosed chamber. Subsequently adsorbed layer thicknesses were determined by ellipsometry, and surface free energies were calculated from contact angle data.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 20:10:39 GMT 2023
by
admin
on
Sat Dec 16 20:10:39 GMT 2023
|
Record UNII |
8ZYQ1474W7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A01AA51
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
27
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
CFR |
21 CFR 355.70
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
WHO-VATC |
QA01AA01
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
EPA PESTICIDE CODE |
75202
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
WHO-ATC |
A12CD01
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
WHO-VATC |
QA12CD01
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
CFR |
21 CFR 355.60
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
CFR |
21 CFR 355.20
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
WHO-ATC |
A01AA01
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
CFR |
21 CFR 355.10
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
CFR |
21 CFR 355.50
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
CFR |
21 CFR 355.55
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
||
|
NCI_THESAURUS |
C802
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1528
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
m10024
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | Merck Index | ||
|
Fluoride therapy
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
1614002
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
C832
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
28741
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
7681-49-4
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
D012969
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
SODIUM FLUORIDE
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
SUB15285MIG
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
8ZYQ1474W7
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
100000091554
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
1766
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
DTXSID2020630
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
4243
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
5235
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
8ZYQ1474W7
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
sodium fluoride
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
231-667-8
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
9873
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB09325
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
77385
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | |||
|
SODIUM FLUORIDE
Created by
admin on Sat Dec 16 20:10:39 GMT 2023 , Edited by admin on Sat Dec 16 20:10:39 GMT 2023
|
PRIMARY | Description: A white powder; odourless. Solubility: Soluble in water; practically insoluble in ethanol (~750 g/l) TS. Category: Mineral salt. Storage: Sodium fluoride should be kept in a well-closed container. Definition: Sodium fluoride contains not less than 98.0% and not more than 101.0% of NaF, calculated with reference to the dried substance. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |